Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Coronary Disease

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolad, I; Delafontaine, P1

Reviews

1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Coronary Disease

ArticleYear
Endothelial dysfunction: its role in hypertensive coronary disease.
    Current opinion in cardiology, 2005, Volume: 20, Issue:4

    Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants

2005